Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P. Fendler, Rainer Hamacher, Justin Ferdinandus et al.|Clinical Cancer Research|2022Cited by 145
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the<sup>68</sup>Ga-FAPI PET Observational TrialLukas Kessler, Jens T. Siveke, Nader Hirmas et al.|Journal of Nuclear Medicine|2023Cited by 34